Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
A2A Pharmaceuticals, Inc. Insider Profile
11 Followers
A2A Pharmaceuticals, Inc., Ten Percent Owner at Biomea Fusion, holds 3.50M shares in Biomea Fusion (Ticker: BMEA). Most recently, A2A Pharmaceuticals, Inc. Sold $125,000 shares of Biomea Fusion on Jun 02, 2023 for an estimated value of 4.26M.
A2A Pharmaceuticals, Inc. Biomea Fusion (BMEA)Ten Percent Owner
Biomea Fusion (BMEA)
Ten Percent Owner
Ranked #98,673 out of 102,576 Corporate Insiders
Profitable Transactions
4 out of 8 Profitable Transactions
Average Return
-46.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of A2A Pharmaceuticals, Inc.'s holdings
Insider Roles
Ten Percent Owner
Roles that A2A Pharmaceuticals, Inc. holds in companies
Most Profitable Insider Trade
The most profitable trade made by A2A Pharmaceuticals, Inc.
A2A Pharmaceuticals, Inc.'s Trading History
List of latest transactions for each holding click on a transaction to see A2A Pharmaceuticals, Inc.'s performance on stock
You May Also Like
A2A Pharmaceuticals, Inc. insider profile FAQ
What is the percentage of profitable transactions made by A2A Pharmaceuticals, Inc.?
The percentage of profitable transactions made by A2A Pharmaceuticals, Inc. is 50%.
What is the average return per transaction made by A2A Pharmaceuticals, Inc.?
The average return per transaction made by A2A Pharmaceuticals, Inc. is -46.80%.
What stocks does A2A Pharmaceuticals, Inc. hold?
A2A Pharmaceuticals, Inc. holds: BMEA stocks.
What was A2A Pharmaceuticals, Inc.’s latest transaction?
A2A Pharmaceuticals, Inc. latest transaction was an Informative Sell of $4.26M.
What was A2A Pharmaceuticals, Inc.'s most profitable transaction?
A2A Pharmaceuticals, Inc.’s most profitable transaction was an Informative Buy of BMEA stock on April 6, 2023. The return on the trade was 19.30%.
What is A2A Pharmaceuticals, Inc.'s role in Biomea Fusion?
A2A Pharmaceuticals, Inc.'s role in Biomea Fusion is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.